During the past decade, Clinica Renaca conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Clinica Renaca" are "Acute Coronary Syndrome" (1 trials), "Coronary Artery Disease" (1 trials), "Influenza" (1 trials), "Myocardial Infarction" (1 trials) and "Nonalcoholic Steatohepatitis (NASH) With Fibrosis" (1 trials). Many other conditions were trialed in "Clinica Renaca" in a lesser frequency.

Most popular intervention types in "Clinica Renaca" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials), "Elafibranor" (1 trials), "MHAA4549A" (1 trials) and "Oseltamivir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinica Renaca" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Clinica Renaca". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Clinica Renaca, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clinica Renaca, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".